HAMBURG (dpa-AFX) - German drug maker Evotec announced a collaboration
with US pharmaceutical company Pfizer to advance drug discovery
efforts in France.

As per the multi-year master research collaboration and option and
license agreement, the companies will initially focus on early
discovery research for metabolic and infectious diseases.

Evotec, based in Hamburg, noted that the research will be carried out
at its sites in France, includingCampus Curie in Toulouse, a
state-of-the-art research site with capabilities spanning high
throughput screening, in vitro and in vivo biology, proteomics and
metabolomics.

Evotec said it will receive research support funding from Pfizer and
be eligible for potential milestones and royalties related to success
of the programmes.


Copyright dpa